Q4 Earnings Forecast for Calian Group Issued By Desjardins

Key Points

• Desjardins reduced its Q4 2025 EPS estimate for Calian Group from $1.25 to $1.05, maintaining a "Buy" rating with a price target of $59.00.
• The company announced a quarterly dividend of $0.28 per share, translating to an annualized dividend yield of 2.4% and a high dividend payout ratio of 119.93%.
• Calian Group operates in multiple industries, primarily generating revenue from its Health segment, which includes various clinical services.

Calian Group Ltd. (TSE:CGY - Free Report) - Equities researchers at Desjardins reduced their Q4 2025 earnings estimates for shares of Calian Group in a research report issued on Wednesday, August 13th. Desjardins analyst B. Poirier now forecasts that the company will post earnings of $1.05 per share for the quarter, down from their previous estimate of $1.25. Desjardins currently has a "Buy" rating and a $59.00 price target on the stock. The consensus estimate for Calian Group's current full-year earnings is $4.95 per share. Desjardins also issued estimates for Calian Group's FY2026 earnings at $4.37 EPS.

Other research analysts have also issued research reports about the stock. CIBC boosted their target price on shares of Calian Group from C$50.00 to C$59.00 in a research report on Monday, July 21st. Ventum Financial cut their target price on shares of Calian Group from C$60.00 to C$58.00 and set a "buy" rating for the company in a research report on Thursday, August 14th. Canaccord Genuity Group cut their target price on shares of Calian Group from C$75.00 to C$60.00 and set a "buy" rating for the company in a research report on Thursday, May 22nd. Finally, Royal Bank Of Canada cut their target price on shares of Calian Group from C$60.00 to C$58.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of C$60.67.

Calian Group Stock Up 0.9%

Shares of CGY stock traded up C$0.45 on Monday, hitting C$49.00. The company's stock had a trading volume of 4,458 shares, compared to its average volume of 34,593. The stock has a market capitalization of C$581.68 million, a price-to-earnings ratio of 52.47, a P/E/G ratio of 2.50 and a beta of 0.88. The company has a debt-to-equity ratio of 39.54, a current ratio of 1.29 and a quick ratio of 1.20. Calian Group has a fifty-two week low of C$37.70 and a fifty-two week high of C$53.36. The firm's fifty day moving average price is C$49.53 and its 200-day moving average price is C$45.82.

Insider Activity

In related news, Senior Officer Kevin Lee Ford acquired 1,000 shares of the company's stock in a transaction dated Monday, May 26th. The shares were bought at an average price of C$38.05 per share, for a total transaction of C$38,050.00. In the last quarter, insiders have bought 1,440 shares of company stock worth $58,354. Insiders own 0.63% of the company's stock.

Calian Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Stockholders of record on Tuesday, September 9th will be issued a dividend of $0.28 per share. The ex-dividend date is Tuesday, August 26th. This represents a $1.12 annualized dividend and a dividend yield of 2.3%. Calian Group's payout ratio is presently 119.93%.

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.